Showing results (2631-2640 of 25,162) with videos related to

Sort By:
Pageof 2,517
Oncotarget|June 23, 2018
Favorable prognostic role of tropomodulins in neuroblastomaPaola Bettinsoli, Giulia Ferrari-Toninelli, Sara Anna Bonini, et al.
Oncotarget|June 23, 2018
Global metabolite profiling analysis of lipotoxicity in HER2/neu-positive breast cancer cellsJan Baumann, Mostafa Kokabee, Jason Wong, et al.
Oncotarget|June 23, 2018
Effect of combined inhibition of p110 alpha PI3K isoform and STAT3 pathway in ovarian cancer platinum-based resistanceAugustin Le Naour, Renaud Mevel, Benoit Thibault, et al.
Oncotarget|June 23, 2018
Construction and characterization of a new TRAIL soluble form, active at picomolar concentrationsMatias Eliseo Melendez, Renato José Silva-Oliveira, Anna Luiza Silva Almeida Vicente, et al.
Oncotarget|June 23, 2018
Discovery and optimization of cardenolides inhibiting HSF1 activation in human colon HCT-116 cancer cellsAlina D Nikotina, Lidia Koludarova, Elena Y Komarova, et al.
Oncotarget|June 22, 2018
Integrated epigenetic and genetic analysis identifies markers of prognostic significance in pediatric acute myeloid leukemiaJatinder K Lamba, Xueyuan Cao, Susana C Raimondi, et al.
Oncotarget|June 22, 2018
The dynamics of HER2 status in esophageal adenocarcinomaAafke Creemers, Eva A Ebbing, Gerrit K J Hooijer, et al.
Oncotarget|June 22, 2018
Nucleolin facilitates nuclear retention of an ultraconserved region containing TRA2β4 and accelerates colon cancer cell growthYuzuru Satake, Yuki Kuwano, Tatsuya Nishikawa, et al.
Oncotarget|June 26, 2018
Targeting autophagy sensitises lung cancer cells to Src family kinase inhibitorsEwa Rupniewska, Rajat Roy, Francesco A Mauri, et al.
Oncotarget|June 26, 2018
Neoadjuvant chemotherapy in breast cancer: a dose-dense schedule in real life and putative role of PIK3CA mutationsValentina Cocciolone, Katia Cannita, Alessandra Tessitore, et al.
Pageof 2,517